Delivery Order SPE2DB20D3103-SPE2DB25FQ2R7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of BOTOX Cosmetic 100-unit vials with a ceiling value of $1,787.40. This firm fixed-price delivery order, which is expected to be completed by October 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract was competitively awarded without set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX Cosmetic under a firm fixed-price contract valued at $1,787.40. The award, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $21,534 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX, with a completion date of August 12, 2025. This non-set-aside competitive award was issued on July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox Cosmetic 100 Unit Vials under a firm fixed-price contract with a ceiling value of $3,574.80. The award was made on September 2, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside delivery order was competitively awarded and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement programs, with...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,419.20 for 200-unit vials of BOTOX on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a delivery order valued at $24,090 to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on August 7, 2025. This firm fixed-price contract represents a non-competitive delivery order placed against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,306.80 delivery order on August 5, 2025, for BOTOX 100 Unit Vials, with an ultimate completion date of August 26, 2025. This firm fixed-price contract is unclassified as a set-aside and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $3,574.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BOTOX Cosmetic 100 Unit Vials, with an ultimate completion date of September 30, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.50 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2R7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Botox Cosmetic 50 Unit Vials with a ceiling value of $12,329.00. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp serves as a critical federal medical procurement vendor with an extensive portfolio of pharmaceutical and medical supply deliveries to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting history demonstrates its capability to fulfill diverse medical product requirements through open competition, ranging from routine medication supplies to specialized healthcare commodities. This award reflects the company's ongoing role in supporting military healthcare procurement through the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 9/11/25 |